Aptamers in Immunotherapy

Abstract

Human Gene TherapyVol. 19, No. 5 ReviewsAptamers in ImmunotherapyClaudia M. Dollins, Smita Nair, and Bruce A. SullengerClaudia M. DollinsSearch for more papers by this author, Smita NairSearch for more papers by this author, and Bruce A. SullengerSearch for more papers by this authorPublished Online:28 May 2008https://doi.org/10.1089/hum.2008.045AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByChemical Modifications for a Next Generation of Nucleic Acid Aptamers29 April 2022 | ChemBioChem, Vol. 23, No. 15Generation and Selection of Specific Aptamers Targeting Brucella Species through an Enhanced Cell-SELEX Methodology30 May 2022 | International Journal of Molecular Sciences, Vol. 23, No. 11Visual detection of tropomyosin, a major shrimp allergenic protein using gold nanoparticles (AuNPs)-assisted colorimetric aptasensor12 February 2021 | Marine Life Science & Technology, Vol. 3, No. 3Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications30 June 2020 | ACS Applied Materials & Interfaces, Vol. 13, No. 8Alternative Analyte-Binding Compounds for Immunosensor-Like Point-of-Care Application13 October 2020Aptamers for Thrombotic Diseases26 March 2021DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant17 December 2020 | Scientific Reports, Vol. 10, No. 1A Homodimeric Aptamer Variant Generated from Ligand-Guided Selection Activates the T Cell Receptor Cluster of Differentiation 3 ComplexMolecular Therapy - Nucleic Acids, Vol. 22Biosensing of microcystins in water samples; recent advancesBiosensors and Bioelectronics, Vol. 165Inhibition of miR‐155 in MCF‐7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer31 January 2020 | Journal of Cellular Physiology, Vol. 235, No. 10Ligand Guided Selection (LIGS) of Artificial Nucleic Acid Ligands against Cell Surface Targets2 December 2019 | ACS Applied Bio Materials, Vol. 3, No. 5HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development9 January 2020 | Archivum Immunologiae et Therapiae Experimentalis, Vol. 68, No. 1 Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review 1 June 2020 | International Journal of Nanomedicine, Vol. Volume 15A Bottom-Up Approach for Developing Aptasensors for Abused Drugs: Biosensors in Forensics1 October 2019 | Biosensors, Vol. 9, No. 4Aptamer Oligonucleotides as Potential Therapeutics in Hematologic DiseasesMini-Reviews in Medicinal Chemistry, Vol. 19, No. 10Dye Coupled Aptamer-Captured Enzyme Catalyzed Reaction for Detection of Pan Malaria and P. falciparum Species in Laboratory Settings and Instrument-Free Paper-Based Platform22 February 2019 | Analytical Chemistry, Vol. 91, No. 6DNA NanostructuresAdvances in the oligonucleotide-based sensor technology for detection of pharmaceutical contaminants in the environmentComplexes of DNA with fluorescent dyes are effective reagents for detection of autoimmune antibodies15 May 2017 | Scientific Reports, Vol. 7, No. 1Emerging Biorecognition and Transduction Schemes for Rapid Detection of Pathogenic Bacteria in Food11 September 2017 | Comprehensive Reviews in Food Science and Food Safety, Vol. 16, No. 6A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor EffectsMolecular Therapy - Nucleic Acids, Vol. 5Cancer immunotherapy via nucleic acid aptamersInternational Immunopharmacology, Vol. 29, No. 2Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease Weibin Li and Xiaopeng Lan20 July 2015 | Nucleic Acid Therapeutics, Vol. 25, No. 4Selection of HBsAg-Specific DNA Aptamers Based on Carboxylated Magnetic Nanoparticles and Their Application in the Rapid and Simple Detection of Hepatitis B Virus Infection19 May 2015 | ACS Applied Materials & Interfaces, Vol. 7, No. 21Development of Aptamer oligonucleotides as Anticoagulants and Antithrombotics for Cardiovascular Diseases: Current StatusThrombosis Research, Vol. 134, No. 4Aptamer-targeted Antigen DeliveryMolecular Therapy, Vol. 22, No. 7Functionalized DNA Nanostructures for Nanomedicine24 June 2013 | Israel Journal of Chemistry, Vol. 53, No. 8Electrochemical Analysis of Proteins31 October 2012Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells Jonathan W. Kotula, Elizabeth D. Pratico, Xin Ming, Osamu Nakagawa, Rudolph L. Juliano, and Bruce A. Sullenger15 June 2012 | Nucleic Acid Therapeutics, Vol. 22, No. 3Aptamers and Their Biological Applications9 January 2012 | Sensors, Vol. 12, No. 1Molecular aptamers for drug deliveryTrends in Biotechnology, Vol. 29, No. 12Design Strategies for Aptamer-Based Biosensors4 May 2010 | Sensors, Vol. 10, No. 5Commandeering a biological pathway using aptamer-derived molecular adaptors6 January 2010 | Nucleic Acids Research, Vol. 38, No. 7Therapeutic Nucleic AcidsCancer immunotherapy3 August 2009 | Critical Reviews in Clinical Laboratory Sciences, Vol. 46, No. 4Logic Gates and Antisense DNA Devices Operating on a Translator Nucleic Acid Scaffold9 June 2009 | ACS Nano, Vol. 3, No. 7An Exosite-Specific ssDNA Aptamer Inhibits the Anticoagulant Functions of Activated Protein C and Enhances Inhibition by Protein C InhibitorChemistry & Biology, Vol. 16, No. 4 Volume 19Issue 5May 2008 InformationMary Ann Liebert, Inc.To cite this article:Claudia M. Dollins, Smita Nair, and Bruce A. Sullenger.Aptamers in Immunotherapy.Human Gene Therapy.May 2008.443-450.http://doi.org/10.1089/hum.2008.045Published in Volume: 19 Issue 5: May 28, 2008Online Ahead of Print:May 12, 2008PDF download